Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Cancer Research
|
April 2, 2014
Sphingosine kinase 2 promotes acute lymphoblastic leukemia by enhancing MYC expression
Craig T Wallington-Beddoe, Jason A Powell, Daochen Tong, et al.
Plos One
|
May 10, 2012
Disparate in vivo efficacy of FTY720 in xenograft models of Philadelphia positive and negative B-lineage acute lymphoblastic leukemia
Craig T Wallington-Beddoe, Anthony S Don, John Hewson, et al.
Oncotarget
|
May 4, 2017
Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress
Craig T Wallington-Beddoe, Melissa K Bennett, Kate Vandyke, et al.
Molecular Oncology
|
July 10, 2021
Desmoglein-2 expression is an independent predictor of poor prognosis patients with multiple myeloma
Lisa M Ebert, Kate Vandyke, M Zahied Johan, et al.
Neoplasia (New York, N.Y.)
|
November 26, 2021
Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibition
Melissa K Bennett, Manjun Li, Melinda N Tea, et al.
Blood
|
December 14, 2016
Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia
Jason A Powell, Alexander C Lewis, Wenying Zhu, et al.
Blood
|
April 20, 2022
Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemia
Alexander C Lewis, Victoria S Pope, Melinda N Tea, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Cancer Research
|
April 2, 2014
Sphingosine kinase 2 promotes acute lymphoblastic leukemia by enhancing MYC expression
Craig T Wallington-Beddoe, Jason A Powell, Daochen Tong, et al.
Plos One
|
May 10, 2012
Disparate in vivo efficacy of FTY720 in xenograft models of Philadelphia positive and negative B-lineage acute lymphoblastic leukemia
Craig T Wallington-Beddoe, Anthony S Don, John Hewson, et al.
Oncotarget
|
May 4, 2017
Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress
Craig T Wallington-Beddoe, Melissa K Bennett, Kate Vandyke, et al.
Molecular Oncology
|
July 10, 2021
Desmoglein-2 expression is an independent predictor of poor prognosis patients with multiple myeloma
Lisa M Ebert, Kate Vandyke, M Zahied Johan, et al.
Neoplasia (New York, N.Y.)
|
November 26, 2021
Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibition
Melissa K Bennett, Manjun Li, Melinda N Tea, et al.
Blood
|
December 14, 2016
Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia
Jason A Powell, Alexander C Lewis, Wenying Zhu, et al.
Blood
|
April 20, 2022
Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemia
Alexander C Lewis, Victoria S Pope, Melinda N Tea, et al.
Page
of 2